What are the side effects of immunotherapy for Non-Small Cell Lung Cancer
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Side Effects of Immunotherapy for Non-Small Cell Lung Cancer
Immunotherapy is an important treatment option for NSCLC, but it works differently than traditional chemotherapy—and that means the side effects are different too. Let me explain what you should know.
How Immunotherapy Works (And Why Side Effects Differ)
According to the NCCN Guidelines for Metastatic Non-Small Cell Lung Cancer, immunotherapy uses immune checkpoint inhibitors (ICIs) that work by "restoring the ability of immune T cells to kill lung cancer cells." These drugs essentially remove the "brakes" that cancer cells use to hide from your immune system.
The challenge is that when your immune system becomes more active, it can sometimes attack healthy cells by mistake. This is why immunotherapy side effects are unique compared to chemotherapy.
Common Immune-Related Side Effects
The NCCN Guidelines note that "immune checkpoint inhibitors may allow your immune cells to attack your healthy cells. Immune-related side effects can occur during or after treatment."
Common side effects include:
- Fatigue (tiredness)
- Skin rashes or itching
- Diarrhea or constipation
- Nausea
- Loss of appetite
- Cough or shortness of breath
- Headache
Serious Immune-Related Side Effects (Less Common But Important)
According to the NCCN Guidelines, more serious side effects can affect different body systems:
- Lung problems: Pneumonitis (inflammation of the lungs) - this is one of the most serious potential complications
- Heart problems: Myocarditis (inflammation of the heart muscle)
- Endocrine disorders: Problems with your thyroid, pituitary gland, or pancreas
- Digestive tract: Severe inflammation or tears in your digestive system
- Liver problems: Elevated liver enzymes or hepatitis
- Kidney problems: Changes in kidney function
The NCCN Guidelines emphasize that "atezolizumab, cemiplimab-rwlc, durvalumab, nivolumab, or pembrolizumab should be discontinued for patients with severe or life-threatening pneumonitis or myocarditis."
When Immunotherapy May NOT Be Safe
According to the NCCN Guidelines for Patients, immunotherapy may not be appropriate if you:
- Have an autoimmune disease (where your immune system already attacks your own body)
- Are taking medications that suppress your immune system
- Have had an organ transplant
- Have poor overall health status (performance status of 3 or 4)
Managing Side Effects
The NCCN Guidelines recommend that "for patients with immune-mediated adverse events, intravenous high-dose corticosteroids should be administered based on the severity of the reaction." This means your medical team can often manage side effects effectively with appropriate medications.
Important Questions to Ask Your Oncology Team
Since side effects vary from person to person, here are specific questions to discuss:
-
Which specific immunotherapy drug are you recommending for me, and what are the most common side effects I should watch for?
-
What symptoms should I report immediately versus what I can manage at home? (For example, when does a rash need urgent attention?)
-
How will you monitor me for serious side effects like pneumonitis or heart problems? (This typically involves blood tests and imaging)
-
If I develop a serious side effect, what's the plan? (Will the drug be paused, stopped, or adjusted?)
-
Are there any of my current medications or health conditions that might increase my risk of side effects?
-
What support resources are available if I experience side effects? (Nurse hotlines, symptom management programs, etc.)
The Bottom Line
While immunotherapy side effects can be serious, they're often manageable with proper monitoring and medical support. The NCCN Guidelines emphasize that healthcare providers should "be aware of the spectrum of potential immune-mediated adverse events, know how to manage the adverse events, and educate their patients about possible side effects."
Most patients tolerate immunotherapy well, and for many with NSCLC, the benefits in controlling cancer outweigh the risks. Your oncology team will work with you to catch and manage any side effects early.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Non-Small Cell Lung Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for Non-Small Cell Lung Cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
What is the survival rate for advanced NSCLC
I appreciate this important question. However, I need to be honest about what I can and cannot tell you based on the available evidence. What the Gu
What is the survival rate for advanced NSCLC non-small cell lung cancer
I appreciate this important question. However, I need to be direct with you: I cannot and should not provide you with a specific survival rate number,